Thomas S. Harrison focuses on Immunology, Meningitis, Internal medicine, Cryptococcosis and Fluconazole. The various areas that he examines in his Immunology study include Cryptococcus, Urine and Genus Candida. His Meningitis research incorporates elements of Incidence, Mortality rate, Sida, Retrospective cohort study and Prospective cohort study.
His Internal medicine research includes themes of Gastroenterology, Amphotericin B and Surgery. Thomas S. Harrison combines subjects such as Immune system, Immunity, Mycosis and Cryptococcus neoformans with his study of Cryptococcosis. His Fluconazole research includes elements of Pharmacotherapy and Immune reconstitution inflammatory syndrome.
Thomas S. Harrison mostly deals with Meningitis, Internal medicine, Immunology, Cryptococcosis and Fluconazole. His Meningitis study incorporates themes from Pharmacokinetics, Incidence, Virology, Cryptococcal meningitis and Asymptomatic. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Surgery and Tuberculosis.
His Immunology study combines topics from a wide range of disciplines, such as Mortality rate, Cryptococcus, Immune reconstitution inflammatory syndrome and Cerebrospinal fluid. Thomas S. Harrison usually deals with Cryptococcosis and limits it to topics linked to Acquired immunodeficiency syndrome and Health care. His biological study deals with issues like Amphotericin B, which deal with fields such as First episode, Pharmacotherapy and Clinical trial.
The scientist’s investigation covers issues in Internal medicine, Cryptococcal meningitis, Meningitis, Fluconazole and Flucytosine. His biological study spans a wide range of topics, including Gastroenterology and Tuberculosis. His work deals with themes such as Subclinical infection and Immunology, Cryptococcosis, which intersect with Meningitis.
In his research, Combination therapy is intimately related to Cryptococcus, which falls under the overarching field of Immunology. His Fluconazole research is multidisciplinary, incorporating elements of Asymptomatic and Incidence. His studies deal with areas such as Public sector and Cryptococcus neoformans as well as Flucytosine.
His primary areas of investigation include Internal medicine, Fluconazole, Meningitis, Flucytosine and Amphotericin B. His research links Azithromycin with Internal medicine. His study in Fluconazole is interdisciplinary in nature, drawing from both Cryptococcus and Combination therapy.
His studies in Meningitis integrate themes in fields like Asymptomatic and Incidence. His work carried out in the field of Flucytosine brings together such families of science as Pediatrics and Cryptococcus neoformans. He has included themes like Cryptococcal meningitis and Confidence interval in his Amphotericin B study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
John R. Perfect;William E. Dismukes;Francoise Dromer;David L. Goldman.
Clinical Infectious Diseases (2010)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Annemarie E Brouwer;Adul Rajanuwong;Wirongrong Chierakul;George E Griffin.
The Lancet (2004)
High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
Amina Jindani;Thomas S. Harrison;Andrew J. Nunn;Patrick P.J. Phillips.
The New England Journal of Medicine (2014)
Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole
Tihana Bicanic;Graeme Meintjes;Robin Wood;Madeleine Hayes.
Clinical Infectious Diseases (2007)
Screening for Cryptococcal Antigenemia in Patients Accessing an Antiretroviral Treatment Program in South Africa
Joseph N Jarvis;Stephen D Lawn;Monica Vogt;Nonzwakazi Bangani.
Clinical Infectious Diseases (2009)
Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes
Joseph N. Jarvis;Tihana Bicanic;Angela Loyse;Daniel Namarika.
Clinical Infectious Diseases (2014)
Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy.
Peter R. Williamson;Joseph N. Jarvis;Anil A. Panackal;Matthew C. Fisher.
Nature Reviews Neurology (2017)
HIV-associated cryptococcal meningitis
Joseph N Jarvis;Thomas S Harrison.
Evaluation of a Novel Point-of-Care Cryptococcal Antigen Test on Serum, Plasma, and Urine From Patients With HIV-Associated Cryptococcal Meningitis
JN Jarvis;A Percival;S Bauman;J Pelfrey.
Clinical Infectious Diseases (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: